USA flag logo/image

An Official Website of the United States Government

A COMPREHENSIVE OUTCOME SCALE FOR OUTPATIENT PSYCHIATRY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
61080
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
MH057603
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
PSYCH PRODUCTS PRESS
PSYCH PRODUCTS PRESS BOX 228 EAST GREENWICH, RI 02818
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2002
Title: A COMPREHENSIVE OUTCOME SCALE FOR OUTPATIENT PSYCHIATRY
Agency: HHS
Contract: 2R44MH057603-02A2
Award Amount: $999,162.00
 

Abstract:

DESCRIPTION (provided by applicant): The proposed project is related to NIMH research topic Assessment of Emotional and Psychological States. The goal is to develop a multidimensional, modular, self-report questionnaire that evaluates the course and outcome of psychiatric treatment. The Multidimensional Assessment of Symptoms and Psychosocial Functioning (MASP) is designed to assess symptom severity of the most commonly diagnosed DSM-IV Axis I disorders, as well as psychosocial functioning and quality of life. Items on the scale are based directly on DSM-IV diagnostic criteria, and the scale is organized for immediate availability of information. The scale's modular structure lends itself to selective subscale administration for ongoing treatment outcome assessment. Phase I successfully attained the following goals: (1) demonstration of the understandability of the MASP?s items; (2) demonstration of the feasibility of using the MASP in clinical settings; (3) establishment of the internal consistency and test-retest reliability of all MASP subscales, (4) demonstration of the discriminant and convergent validity of the MASP subscales, (5) demonstration of the reliability and validity of the MASP items, and (6) support for the factor structure of the scale. The final, and most important, steps in the development of the MASP is to demonstrate that the instrument is sensitive to clinical change, and to establish MASP subscale scores corresponding to different severity ranges.

Principal Investigator:

Diane Young
4012770706
DYOUNG@LIFESPAN.ORG

Business Contact:

Mark Zimmerman
4018856746
MZIMMERMAN@LIFESPAN.ORG
Small Business Information at Submission:

PSYCH PRODUCTS PRESS
PSYCH PRODUCTS PRESS BOX 228 EAST GREENWICH, RI 02818

EIN/Tax ID: 232729864
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No